Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Sulacare AS
AS
Active
Org 827803022
Høgåsveien 8, 8616
Mo I Rana
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
2 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Sulacare AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MS
Marie Steinfjell
Chief Executive Officer
Chief Executive Officer
2024
Former (1)
TS
Tuva Sveås Okkenhaug
Observer
Observer
2023 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
MS
Marie Steinfjell
Board of Directors
Board of Directors
2023
RC
Rune Christian Nystad
Chairman
Chairman
2026
NL
Nikolai Lie Steinfjell
Board of Directors
Board of Directors
2023
AK
Anette Kristin Bø Andreassen
Board of Directors
Board of Directors
2024
Former (3)
KS
Ketil Sundelin
Board of Directors
Board of Directors
2026 – 2026
CK
Cristina Kvam Santos
Chairman
Chairman
2023 – 2024
VU
Veronica Ugedal
Chairman
Shareholders
As of last annual report
Cofounder Iii As — 14.82%
Arctic Seed As — 5.35%
Deja Invest As — 3.95%
Fjellreven As — 2.2%
Tromsø Eiendomsutvikling As — 1.98%
Kupa As — 1.61%
Evertsen Holding As — 1.46%
Tenari As — 1.46%
Agn As — 1.46%
Vegard Monsen As — 1.2%
35%
Shareholder
Type
Ownership
Votes
Since
Cofounder Iii As
Company
14.82%
14.82%
2025
Arctic Seed As
Company
5.35%
5.35%
2025
Deja Invest As
Company
3.95%
3.95%
2025
Fjellreven As
Company
2.2%
2.2%
2025
Tromsø Eiendomsutvikling As
Company
1.98%
1.98%
2025
Kupa As
Company
1.61%
1.61%
2025
Evertsen Holding As
Company
1.46%
1.46%
2025
Tenari As
Company
1.46%
1.46%
2025
Agn As
Company
1.46%
1.46%
2025
Vegard Monsen As
Company
1.2%
1.2%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Sulacare AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Chairman
2024 – 2026